Call centre awards success for eg solutions

STAFFORDSHIRE-based back office optimisation software firm, eg solutions, has been voted as one of the top contact centre technologies in the 2014 Call Centre Helper ‘Top 10 Contact Centre Technology’ Awards.

The awards, run annually, recognise the best products on the market and are designed to help contact centre managers make informed decisions about the technologies they invest in.

Elizabeth Gooch, acting chief executive of eg solution, said: “eg operational intelligence® was the first purpose built back office workforce optimisation software product on the market. It was designed to solve real problems experienced by our customers and we have been constantly refining the solution over time to meet the strategic needs of our customers.

“However, this award is significant because it is a call centre award voted for by customers and users of the technology, and not just a panel of judges. Increasingly, our software is being used to manage customer contact in both the front and back office to reduce the end-to-end customer journey time of all customer contact. So it is good to be recognised by the whole of the contact centre, not just the back office.”

The firm has recently launched the latest version of the eg operational intelligence® software suite, which includes a number of platform and functionality enhancements. The firm is hoping this will enable it to continue winning new business.

Wincanton appointment for Carillion FD

THE group finance director of Wolverhampton-based support services group, Carillion has been appointed a non-executive director of logistics group Wincanton.

The appointment of Richard Adam will take effect from June 1, 2014. Adam has been GFD with Carillion since 2007. He was previously non-executive director and chairman of the auditcommittee of SSL International plc and Zattikka plc. From appointment, he will join Wincanton’s audit, remuneration and nomination committees and it is envisaged he will chair the audit committee in due course.

Wincanton has also announced that after nearly nine years as a non-executive director, Jonson Cox will step down from the board with effect from May 31, 2014. Cox is the former chairman of UK Coal.

Steve Marshall, chairman of Wincanton said, “I am delighted that Richard will be joining the board. Richard is an experienced Group Finance Director and audit committee chair. He also has hands on experience of the competitive business services and contracting environment of the type in which Wincanton operates.”

Clinigen announces new named patient program

STAFFORDSHIRE pharmaceuticals group, Clinigen, has agreed a new named patient programme with Abiogen Pharma.

The programme, Clinigen Global Access Programs, is to provide Nerixia (neridronic acid) – owned by Abiogen – to individual patients with Osteogenesis imperfecta (OI) through their Healthcare Professional.

Clinigen GAP will supply the drug to countries within the EU, except for in Italy where the drug is currently licensed and commercially available. Nerixia, an aminobisphosphonate, is indicated for the treatment of OI, a congenital disorder characterised by brittle bones. No other bisphosphonate is currently licensed for the condition in Europe.

Mark Corbett, senior vice president, Clinigen GAP said, “Nerixia has the potential to make a huge difference to the lives of individual patients and we are very pleased to be able to implement an access program for this important therapy. With an expanding client base of international pharmaceutical companies and over 30 access programs ongoing we have the expertise, capabilities and regulatory know-how to deliver this bespoke program.”